FOCUS

First Name

Please enter your first name.

Last Name

Please enter your last name.

Degree

Please enter your Degree.

Specialty

Please enter your Specialty.

Address

Please enter your Address.

City

Please enter your City.

Zip

Please enter your Zip Code.

Phone

Please enter your Phone.

Please enter your Email.

0-5 years

6-10 years

11-20 years

21-30 years

30+ years

Urban

Suburban

Rural

Approximately how many patients do you see each week? Digits only.

0-10%

11-25%

26%-50%

51-75%

Over 75%

Approximately how many patients per month do you see with the following conditions (enter a number for each)?

Gastrointestinal Disorders Digits only.

Chronic Liver Disease Digits only.

Please describe your practice setting:

Please enter your Present Employment.

1. The limitations of transient elastography (Fibroscan) in assessing liver stiffness include

A. Obese patients

B. Presence of ascites

C. Cannot assess left lobe of liver

D. All of the above

Incorrect Answer.

2. Which statement is true regarding EUS-guided Shear Wave Elastography (SWE)

A. It requires a special contrast agent

B. It doesn't allow for simultaneous imaging and elastography assessment

C. It can assess liver stiffness of both right and left lobes of the liver, as well as spleen stiffness

D. It causes additional discomfort to the patient

Incorrect Answer.

3. EUS-guided Liver Biopsy may be advantageous over percutaneous liver biopsy in the following:

A. Can obtain biopsies from both right and left lobes of the liver

B. Does not require prolonged post-procedure recovery

C. Can be performed during the same sedation as: endoscopy to assess for varices as well as EUS-guided SWE and porto-systemic pressure gradient measurement

D. All of the above

Incorrect Answer.

4. Which of the following is not considered EUS Tissue Acquisition?

A. EUS Fine Needle Ablation

B. EUS Fine Needle Aspiration

C. EUS Fine Needle Core Biopsy

D. EUS Fine Needle Forceps Biopsy

Incorrect Answer.

5. Should early catheter drainage be performed in all patients with infected necrosis?

A. Yes drainage should be done immediately upon diagnosis of infected necrosis

B. Catheter based drainage of infected necrosis should always be avoided

C. No but early drainage can be considered in patients with deterioration despite medical management

Incorrect Answer.

6. Based on a recent randomized trial, should plastic stents be routinely placed after removal of a metal stent used to drainage walled off pancreatic necrosis in patients with disconnected pancreatic duct

A. Yes, plastic stents are always necessary in disconnected pancreatic duct

B. No, the metal stent should be left in place

C. No, a randomized trial has not shown decreased recurrence of pancreatic fluid collections with plastic stents after metal stent removal

D. Yes, plastic stents will prevent the development of pancreatic insufficiency

Incorrect Answer.

7. Which of the following is not one of the high-risk stigmata of mucinous pancreatic cysts that should lead to consideration of operative treatment in a surgically-fit individual?

A. Main pancreatic duct ≥10 mm

B. Mural nodule >= 5mm

C. Cyst size >= 3 cm

D. Obstructive jaundice

Incorrect Answer.

Describe current guidelines for the diagnosis and management of gastrointestinal disorders

Excellent

Very Good

Good

Fair

Poor

Employ an evidence-based approach to the management of gastrointestinal disorders

Excellent

Very Good

Good

Fair

Poor

Identify new advances presented at 2022 DDW and assess their potential impact on clinical practice

Excellent

Very Good

Good

Fair

Poor

2. These learning objectives did or will impact my:
(select all that apply)

Knowledge

Competence

Performance

Patient Outcomes

3. Please comment if the above objectives were not met

Knowledge of subject matter

Excellent

Very Good

Good

Fair

Poor

Effectiveness of delivery

Excellent

Very Good

Good

Fair

Poor

Responsiveness to questions

Excellent

Very Good

Good

Fair

Poor

5. Please comment on the effectiveness of the speakers

6. What percentage of information presented in this activity will be of use to you?

20%

40%

60%

80%

100%

The online platform was conducive to learning

Excellent

Very Good

Good

Fair

Poor

There was sufficient time for questions and answers

Excellent

Very Good

Good

Fair

Poor

8. Please comment on the activity logistics

9. The content of this activity matched my current (or potential) scope of practice.

Yes

No, please explain

10. Was this activity scientifically sound and free of commercial bias* or influence?

* Commercial bias is defined as a personal judgment in favor of a specific product or service of a commercial interest.

Yes

No, please explain

11. The educational activity will enhance my professional effectiveness in treating patients

Strongly Agree

Agree

Disagree

Strongly Disagree

Not Applicable

12. The educational activity will result in a change in my practice behavior

Strongly Agree

Agree

Disagree

Strongly Disagree

Not Applicable

13. How will you change your practice as a result of participating in this activity? (select all that apply)

Create/revise protocols, policies, and/or procedures

Change the management and/or treatment of my patients

This activity validated my current practice

I will not make any changes to my practice

Other, please specify

14. Do you plan to make any changes to improve your effectiveness as a healthcare team member?

Yes

Not sure

15. The educational activity will help you with coordinating care with other clinicians on the interprofessional team.

Strongly Agree

Agree

Disagree

Strongly Disagree

Not Applicable

16. This activity improved my ability to perform as a more effective healthcare team member.

Strongly Agree

Agree

Disagree

Strongly Disagree

Not Applicable

17. What new information did you learn during this activity?

18. Please indicate any barriers you perceive in implementing these changes. (select all that apply)

Lack of experience

Lack of resources (equipment)

Lack of time to assess/counsel patients

Lack of consensus of professional guidelines

Lack of opportunity (patients)

Lack of administrative support

Reimbursement/insurance issues

Patient compliance issues

No barriers

Cost

Other

19. If you indicated any barriers, how will you address these barriers in order to implement changes in your knowledge, competency, performance, and/or patients' outcomes?

20. What did you like most about this activity?

21. Comments to help improve this activity?

22. Recommendations for future educational topics.

23. Would you recommend this program to your colleagues?

Yes

No, please explain

24. Please select which type of credits or contact hours you would like to receive:

CME: AMA PRA Category 1 Credits™ (ACCME/MD certificate)

CME: AMA PRA Category 1 Credits™ (ACCME/Non-MD certificate)

I do not wish to claim credits

Nurse License Number

25. Please attest to the time participated in the activity:

I participated in the full activity (6.75 hours).

I participated in only part of the activity

hours

26. Please select if you would like to claim ABIM MOC points or not.

I wish to claim 6.75 ABIM MOC points.

ABIM ID Number

DOB(MM/DD)

I do not wish to claim points

Please enter your Email.

If you have already completed this and would like to download your certificate, please click here

Program Evaluation / Certificate Activity

Post-Test